Achieve Life Sciences, Inc.

NASDAQ:ACHV

Biotechnology

Healthcare
$6.78 -7.00%

-$0.38 today

Market cap
$697.68M
Beta
2.26
P/E (TTM)
-5.1
EPS (TTM)
-$0.97
52W Low $2.00High $6.16

Volume 1.09M

Average 1.44M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$49.47M

FY 2025 · Annual

Investing Cash Flow

$6.11M

FY 2025 · Annual

Financing Cash Flow

$51.53M

FY 2025 · Annual

+6.2% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Depreciation & Amortization250K236K228K229K228K
Deferred Income Tax00000
Stock-Based Compensation2.19M3.27M3.44M5.33M8.76M
Change in Working Capital1.23M79K(778K)2.41M(4.27M)
Accounts Receivables(153K)48K0111K0
Inventory00000
Accounts Payables509K799K(1.04M)1.33M(1.08M)
Other Working Capital878K(768K)264K969K(3.18M)
Other Non-Cash Items41K1.2M2.45M2.09M460K
Operating Cash Flow(29.44M)(37.57M)(24.48M)(29.77M)(49.47M)
Capital Expenditures00(21K)0(3K)
Acquisitions (Net)00000
Purchases of Investments000(47.89M)(24.76M)
Sales of Investments00026.31M30.87M
Other Investing Activities00003K
Investing Cash Flow00(21K)(21.58M)6.11M
Debt Repayment14.93M00(8.3M)5M
Common Stock Issued21.34M19.21M15.3M56.08M46.53M
Common Stock Repurchased00(30K)00
Dividends Paid00000
Other Financing Activities338K103K7K746K0
Financing Cash Flow36.61M19.32M15.28M48.53M51.53M
Effect of Forex Changes(1K)3K(3K)30K3K
Net Change in Cash7.17M(18.25M)(9.23M)(2.79M)8.18M
Free Cash Flow(29.44M)(37.57M)(24.5M)(29.77M)(49.47M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$54.6M
+ D&A$228.0K
+ Stock-Based Comp$8.8M
+ Deferred Tax$0
- Working Capital-$4.3M
+ Other Non-Cash$460.0K
= Operating Cash Flow-$49.5M
- Capex-$3.0K
= Free Cash Flow-$49.5M

Analysis

FY2025 free cash flow is -$49.5M. FCF conversion is 90.5% of net income. Operating cash flow was -$49.5M, with capex of -$3.0K. The largest bridge item is Stock-Based Comp at $8.8M.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
3Initial statement of beneficial ownershipOct 6, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
8-KCurrent reportOct 1, 2026
4Statement of changes in beneficial ownershipAug 21, 2026
SC 13GSC 13G filingAug 17, 2026

Does ACHV generate free cash flow?

Achieve Life Sciences, Inc. (ACHV) generated -$49.47M of free cash flow in fiscal 2025.

How much operating cash flow does ACHV produce?

Operating cash flow was -$49.47M, before capital expenditures of $3,000.00.